Literature DB >> 22883165

Frequency of asymptomatic disease among family members with noncompaction cardiomyopathy.

Kadir Caliskan1, Michelle Michels, Marcel L Geleijnse, Ron T van Domburg, Robert van der Boon, Aggie H M M Balk, Maarten L Simoons.   

Abstract

Noncompaction cardiomyopathy (NCC) is a primary cardiomyopathy characterized by an excessively prominent trabecular meshwork and deep intertrabecular recesses of the left ventricular walls. Most cases are inherited, with a dominant inheritance pattern. The aim of the present study was to determine the prevalence and clinical characteristics of cardiomyopathies in the close relatives of patients with NCC. We evaluated 156, mostly first-degree, family members of 44 adult patients with NCC who agreed to familial screening. A family history of cardiac disease was reported by 16 (36%) of the 44 patients, including premature sudden death in 8 families (18%). NCC (n = 32) or dilated cardiomyopathy (n = 9) was diagnosed in 41 relatives (26%) by echocardiography (n = 25), contrast echocardiography (n = 6), or magnetic resonance imaging (n = 10). Of these family members, 13 already had known cardiac symptoms and signs, but most (28 of 41) were asymptomatic. Most subjects with NCC had mild to moderate left ventricular dysfunction (n = 29, 71%). After a median follow-up of 55 months (interquartile range 43 to 93), most remained asymptomatic. Four family members were treated with prophylactic implantable cardioverter-defibrillator placement and 23 of those with NCC were treated with drugs, including angiotensin-converting enzyme inhibitors (41%), β blockers (34%), and anticoagulants (17%). In conclusion, there is a high prevalence, mostly asymptomatic, of cardiac disease (26%) among first- and second-degree family members of patients with NCC. This warrants screening and offers an opportunity for early intervention.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22883165     DOI: 10.1016/j.amjcard.2012.07.009

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Genetic Testing Is Not Required for Diagnosing Left Ventricular Hypertrabeculation / Non-Compaction.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Maedica (Buchar)       Date:  2015-03

Review 2.  Evaluation and management of left ventricular noncompaction cardiomyopathy.

Authors:  R Brandon Stacey; Augustus J Caine; W Gregory Hundley
Journal:  Curr Heart Fail Rep       Date:  2015-02

3.  Sudden death due to biventricular non-compaction cardiomyopathy in a 14-year-old.

Authors:  Paul J Cohen; Joseph A Prahlow
Journal:  Forensic Sci Med Pathol       Date:  2014-12-31       Impact factor: 2.007

Review 4.  Non-compaction cardiomyopathy: prevalence, prognosis, pathoetiology, genetics, and risk of cardioembolism.

Authors:  Pedro Carrilho-Ferreira; Ana G Almeida; Fausto J Pinto
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 5.  Genetics of Cardiac Developmental Disorders: Cardiomyocyte Proliferation and Growth and Relevance to Heart Failure.

Authors:  Lisa Wilsbacher; Elizabeth M McNally
Journal:  Annu Rev Pathol       Date:  2016-02-24       Impact factor: 23.472

6.  Loss of consciousness and convulsion induced by a ventricular tachycardia mimicking epilepsy in a patient with noncompaction cardiomyopathy: a case report.

Authors:  S A W G Dello; C Kievit; P H Dunselman; M Alings
Journal:  Neth Heart J       Date:  2014-06       Impact factor: 2.380

7.  Family screening in black patients with isolated left ventricular non-compaction: the Chris Hani Baragwanath experience.

Authors:  Anneen L Basson; Mohammed R Essop; Elena Libhaber; Ferande Peters
Journal:  Cardiovasc J Afr       Date:  2020-03-11       Impact factor: 1.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.